
Loading, please wait...

Loading, please wait...

The landmark Magpie Trial randomized more than 10,000 women with preeclampsia to magnesium sulfate or placebo. Magnesium sulfate substantially reduced the risk of eclampsia and was associated with improvements in several maternal outcomes, without evidence of major harm to the fetus. The trial provided strong support for magnesium sulfate as a standard anticonvulsant strategy in severe preeclampsia. For obstetricians, the key clinical issue is not only prescribing magnesium but identifying which patients require it, monitoring reflexes, respiratory status and urine output, and ensuring rapid availability of calcium gluconate when toxicity is suspected. Blood-pressure control, evaluation for severe features and timely delivery remain separate components of care. The Magpie findings are especially useful in emergency simulation because they turn a high-stakes clinical scenario into a sequence of recognizable decisions: stabilize the mother, prevent seizure, assess maternal and fetal status and determine the appropriate timing of delivery.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


The landmark Magpie Trial randomized more than 10,000 women with preeclampsia to magnesium sulfate or placebo. Magnesium sulfate substantially reduced the risk of eclampsia and was associated with improvements in several maternal outcomes, without evidence of major harm to the fetus. The trial provided strong support for magnesium sulfate as a standard anticonvulsant strategy in severe preeclampsia. For obstetricians, the key clinical issue is not only prescribing magnesium but identifying which patients require it, monitoring reflexes, respiratory status and urine output, and ensuring rapid availability of calcium gluconate when toxicity is suspected. Blood-pressure control, evaluation for severe features and timely delivery remain separate components of care. The Magpie findings are especially useful in emergency simulation because they turn a high-stakes clinical scenario into a sequence of recognizable decisions: stabilize the mother, prevent seizure, assess maternal and fetal status and determine the appropriate timing of delivery.
Today

The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back

A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back

Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
Last week

A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back

A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back